πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7576194

UspA2 nucleic acid of moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572442

Selected antibody compositions for binding to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572448

Combined cancer treatment methods using selected antibodies to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569683

UspA2 nucleic acid of Moraxella catarrhalis

The Board of Regents of the University of Texas System Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563446

Methods and compositions for inducing autoimmunity in the treatment of cancers

The Board of Regents of the University of Texas System Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7556942

Tumor suppressor designated Hippo

The Board of Regents of the University of Texas System Β· Granted Tue Jul 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7550617

Compositions and methods for the treatment of renal and cardiovascular disease

The Board of Regents of the University of Texas System Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7550141

Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547759

Induction of tumor immunity by variants of folate binding protein

The Board of Regents of the University of Texas System Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7538129

Diazonamide A analog

The Board of Regents of the University of Texas System Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7528133

Use of thiazolidinediones derivatives for preventing uterine contractions in premature lab

The Board of Regents of the University of Texas System Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524490

Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a card

The Board of Regents of the University of Texas System Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7517895

Synthetic diazonamides

The Board of Regents of the University of Texas System Β· Granted Tue Apr 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7514095

Fabrication of drug loaded biodegradable polymer fibers

The Board of Regents of the University of Texas System Β· Granted Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7511124

Compositions comprising phosphatidylethanolamine-binding peptides linked to anti-viral age

The Board of Regents of the University of Texas System Β· Granted Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7507716

Method for treating pain with prolactin antagonists

The Board of Regents of the University of Texas System Β· Granted Tue Mar 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7479550

Amyloid Ξ² gene vaccines

The Board of Regents of the University of Texas System Β· Granted Tue Jan 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7473772

Chimeric GB virus B (GBV-B)

The Board of Regents of the University of Texas System Β· Granted Tue Jan 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7468379

Inhibition of osteolytic lesions by SRC kinase inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Dec 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7455833

Methods and compositions for treating viral infections using antibodies and immunoconjugat

The Board of Regents of the University of Texas System Β· Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452971

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System Β· Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7452964

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System Β· Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7446182

Recombinant antibodies for the detection and neutralization of anthrax toxin

The Board of Regents of the University of Texas System Β· Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7435755

CDDO-compounds and combination therapies thereof

The Board of Regents of the University of Texas System Β· Granted Tue Oct 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted